Published in JAMA Network Open, results from the first US trial of home-based sampling for human papillomavirus show that mailing kits to underscreened women could increase cervical cancer screening.
In adolescents, detection of a cervical human papillomavirus (HPV) infection may signal an increased risk of detection of the virus in the oral cavity, but incidence declines after vaccination, according to research from JAMA Network Open.
Using data from more than 60 million individuals, a recent meta-analysis investigated rates of human papillomavirus (HPV)-related diagnoses since the implementation of vaccination programs.
A new systematic review sheds light on whether routine cervical cancer screening results might predict anal HPV16 infection, anal high-grade squamous intraepithelial lesions (HSIL), and anal cancer
A new analysis calls into question current wisdom about the best strategy for cervical cancer screening.
Although human papillomavirus testing with urine is slightly less sensitive than using cervical samples, it may be easier for women than going to a doctor’s office for a Pap smear.
In this Medical News Minute, Dr. Bobby Lazzara discusses some of the reasons why women are avoiding cervical smear testing for HPV.
A therapeutic vaccine may be effective and safe for clearing cervical intraepithelial neoplasia (CIN) 2/3 irrespective of HPV subtype.
A recent study shows just how effective increasing vaccination rates could be towards eliminating cervical cancer.
New research examines whether the virus is also linked with increased risk of cardiovascular disease (CVD).